Agimexpharm Pharmaceutical JSC (HSTC:AGP) EV-to-EBITDA: (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSTC:AGP Agimexpharm Pharmaceutical JSC HSTC:AGP
14 GF Score
Price ₫30,200.00
! 1 Warning Sign
View Full Analysis

What is Agimexpharm Pharmaceutical JSC EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Agimexpharm Pharmaceutical JSC's enterprise value is ₫0.00 Mil. Agimexpharm Pharmaceutical JSC does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Agimexpharm Pharmaceutical JSC's EV-to-EBITDA at this moment.

The historical rank and industry rank for Agimexpharm Pharmaceutical JSC's EV-to-EBITDA or its related term are showing as below:

HSTC:AGP's EV-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 13.305
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-08-20), Agimexpharm Pharmaceutical JSC's stock price is ₫30200.00. Agimexpharm Pharmaceutical JSC does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Agimexpharm Pharmaceutical JSC's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).

Agimexpharm Pharmaceutical JSC  (HSTC:AGP) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Agimexpharm Pharmaceutical JSC's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=30200.00/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Agimexpharm Pharmaceutical JSC EV-to-EBITDA Related Terms

Agimexpharm Pharmaceutical JSC EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Agimexpharm Pharmaceutical JSC's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Agimexpharm Pharmaceutical JSC EV-to-EBITDA Chart

Agimexpharm Pharmaceutical JSC Annual Data
Trend
EV-to-EBITDA

Agimexpharm Pharmaceutical JSC Semi-Annual Data
EV-to-EBITDA

HSTC:AGP vs : EV-to-EBITDA Comparison

For the Drug Manufacturers - General subindustry, Agimexpharm Pharmaceutical JSC's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Agimexpharm Pharmaceutical JSC EV-to-EBITDA vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Agimexpharm Pharmaceutical JSC's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Agimexpharm Pharmaceutical JSC's EV-to-EBITDA falls into.


HSTC:AGP
14GF Score
Agimexpharm Pharmaceutical JSC HSTC:AGP
EV-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Agimexpharm Pharmaceutical JSC EV-to-EBITDA Calculation

Agimexpharm Pharmaceutical JSC's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.000/
=

Agimexpharm Pharmaceutical JSC Business Description

Comparable Companies
Address 27 Nguyen Thai Hoc, My Binh Ward, An Giang Province, Long Xuyen, VNM
Agimexpharm Pharmaceutical JSC is engaged in producing and trading chemical pharmaceuticals and herbal medicines, health supplements, cosmetics, and medical equipment.
14GF Score

Get the complete analysis for HSTC:AGP

EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫30,200.00
Price